loadpatents
name:-0.0020160675048828
name:-0.056413888931274
name:-0.00062203407287598
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Patent Filings

THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES

Patent Applications and Registrations

Patent applications and USPTO patent grants for THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES.The latest application filed is for "imaging methods and computer-readable media".

Company Profile
0.49.1
  • THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES - Bethesda MD US
  • THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES - Rockville MD US
  • THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES - Atlanta GA US
  • The United States of America as represented by the Secretary of the Department of Health and Human Services - Washington DC US
  • The U.S.A as represented by the Secretary of the Department of Health and Human Services - Bethesda MD US
  • The United States of America as represented by the Secretary of the Department of Health and Human Services - Bethesda MD US
  • THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES - Washington DC US
  • The United States of America as represented by the Secretary of the Department of Health and Human Services - Rockville MD US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Human monoclonal antibodies against EPHA4 and their use
Grant 10,934,360 - Ip , et al. March 2, 2
2021-03-02
Chimpanzee adenoviral vector-based filovirus vaccines
Grant 10,584,355 - Sullivan , et al.
2020-03-10
Regenerative tissue grafts and methods of making same
Grant 10,507,187 - Jackson , et al. Dec
2019-12-17
Compositions and methods for dengue virus chimeric constructs in vaccines
Grant 10,449,231 - Stinchcomb , et al. Oc
2019-10-22
Lutzomyia longipalpis polypeptides and methods of use
Grant 10,314,900 - Valenzuela , et al.
2019-06-11
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
Grant 10,314,908 - Sitkovsky , et al.
2019-06-11
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
Grant 10,093,710 - Pavlakis , et al. October 9, 2
2018-10-09
Real-time PCR for the detection of pathogens
Grant 10,072,305 - Wolff , et al. September 11, 2
2018-09-11
HIV-1 genotyping assay for global surveillance of HIV-1 drug resistance
Grant 10,053,741 - Yang , et al. August 21, 2
2018-08-21
Multiplexed spectral lifetime detection of phosphors
Grant 10,054,593 - Bell , et al. August 21, 2
2018-08-21
Influenza antigens and antibodies
Grant 9,975,925 - Stevens , et al. May 22, 2
2018-05-22
Agents and methods to elicit anti-tumor immune response
Grant 9,951,311 - Gu , et al. April 24, 2
2018-04-24
Nicotinic acetylcholine receptor agonists
Grant 9,902,734 - Fitch , et al. February 27, 2
2018-02-27
Lutzomyia longipalpis polypeptides and methods of use
Grant 9,884,100 - Valenzuela , et al. February 6, 2
2018-02-06
Methods of detecting influenza virus
Grant 9,803,251 - Tong October 31, 2
2017-10-31
Replication-competent adenoviral vectors
Grant 9,732,359 - Peng , et al. August 15, 2
2017-08-15
Use of nitrite salts for the treatment of cardiovascular conditions
Grant 9,700,578 - Gladwin , et al. July 11, 2
2017-07-11
Rift valley fever virus replicon particles and use thereof
Grant 9,687,542 - Dodd , et al. June 27, 2
2017-06-27
Human monoclonal antibodies specific for CD22
Grant 9,598,492 - Dimitrov , et al. March 21, 2
2017-03-21
Imaging Methods And Computer-readable Media
App 20170046823 - Sarkar; Susanta Kumar ;   et al.
2017-02-16
Human rotavirus vaccine strains and diagnostics
Grant 9,498,526 - Jiang , et al. November 22, 2
2016-11-22
Pathogenic phlebovirus isolates and compositions and methods of use
Grant 9,421,250 - McMullan , et al. August 23, 2
2016-08-23
Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conserved regions
Grant 9,415,099 - Pavlakis , et al. August 16, 2
2016-08-16
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
Grant 9,403,872 - Leppla , et al. August 2, 2
2016-08-02
N-substituted indenoisoquinolines and syntheses thereof
Grant 9,399,660 - Cushman , et al. July 26, 2
2016-07-26
Methods for detecting Legionella nucleic acids in a sample
Grant 9,394,574 - Winchell , et al. July 19, 2
2016-07-19
N-substituted indenoisoquinolines and syntheses thereof
Grant 9,388,211 - Cushman , et al. July 12, 2
2016-07-12
Lutzomyia longipalpis polypeptides and methods of use
Grant 9,382,302 - Valenzuela , et al. July 5, 2
2016-07-05
Plasmids and phages for homologous recombination and methods of use
Grant 9,371,532 - Court , et al. June 21, 2
2016-06-21
Human monoclonal antibodies specific for CD22
Grant 9,279,019 - Dimitrov , et al. March 8, 2
2016-03-08
SPANX-B polypeptides and their use
Grant 9,238,684 - Arya , et al. January 19, 2
2016-01-19
Replication-competent adenoviral vectors
Grant 9,216,214 - Peng , et al. December 22, 2
2015-12-22
Polysaccharide-protein conjugate vaccines
Grant 9,198,976 - Lee , et al. December 1, 2
2015-12-01
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
Grant 9,187,457 - Gershengorn , et al. November 17, 2
2015-11-17
Methods for preparing complex multivalent immunogenic conjugates
Grant 9,175,033 - Lee November 3, 2
2015-11-03
Suppressors of CpG oligonucleotides and methods of use
Grant 9,163,244 - Klinman , et al. October 20, 2
2015-10-20
Lutzomyia longipalpis polypeptides and methods of use
Grant 9,120,867 - Valenzuela , et al. September 1, 2
2015-09-01
LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis
Grant 9,115,400 - Eriksson , et al. August 25, 2
2015-08-25
N-acetyl mannosamine as a therapeutic agent
Grant 9,095,597 - Huizing , et al. August 4, 2
2015-08-04
Development of dengue virus vaccine components
Grant 9,090,873 - Whitehead , et al. July 28, 2
2015-07-28
Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer
Grant 9,068,165 - Harris , et al. June 30, 2
2015-06-30
Tumor suppressor gene p47ING3
Grant 8,957,015 - Harris , et al. February 17, 2
2015-02-17
Plasmids and phages for homologous recombination and methods of use
Grant 8,859,277 - Court , et al. October 14, 2
2014-10-14
Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors
Grant 8,835,167 - Kashmiri , et al. September 16, 2
2014-09-16
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
Grant 8,828,356 - Gordon , et al. September 9, 2
2014-09-09
Device for amplifying target nucleic acid
Grant 8,822,183 - Brown , et al. September 2, 2
2014-09-02
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
Grant RE45,016 - Whitehead , et al. July 15, 2
2014-07-15
Polysaccharide-protein conjugate vaccines
Grant 8,753,649 - Lee , et al. June 17, 2
2014-06-17
Oligodeoxynucleotide and its use to induce an immune response
Grant 8,741,869 - Klinman , et al. June 3, 2
2014-06-03
Anti-arthropod vector vaccines, methods of selecting and uses thereof
Grant 8,629,260 - Valenzuela , et al. January 14, 2
2014-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed